Biocon Biologics said it has elevated Shreehas Tambe as Managing Director and CEO of the company with immediate effect, according to PTI report. Tambe was Deputy CEO of Biocon Biologics, a subsidiary of Bengaluru-based Biocon. He takes over from Arun Chandavarkar, who will continue to serve as a non-executive, non-independent director on the Biocon Biologics board, the company said…
Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced that it has entered into a definitive agreement with its partner Viatris Inc. Accordingly, Biocon Biologics Ltd. (BBL) will acquire Viatris’ biosimilars business to create a unique fully integrated global biosimilars enterprise. Viatris will receive consideration of up to USD 3.335 billion, including cash up to…
Biocon Biologics has appointed Naveen Narayanan as Chief Human Resources Officer. He will be reporting to Arun Chandavarkar, MD, Biocon Biologics. Narayanan has 25 years’ experience in HR spans across several industries including Hospitality, Supply Chain, Banking, Retail, Travel, and IT and 30+ geographies. Before joining Biocon Biologics, Narayanan was MD – Human Capital Consulting,…
Biocon Biologics Ltd., a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd., announced that Susheel Umesh has joined Biocon Biologics as the Chief Commercial Officer – Emerging Markets (CCO-EMs) w.e.f. March 1, 2021. In this new role, Susheel will drive the company’s business in the Emerging Markets (EMs) and will also…
Biocon Biologics Ltd., a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd., announced that Shreehas Tambe has been promoted to the position of Deputy Chief Executive Officer of Biocon Biologics Limited, effective from March 1, 2021. A Biocon veteran, Shreehas joined Biocon in 1997 and has, since then, taken on positions…